Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.51% | 16.08% | 28.76% | 29.79% | 31.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.51% | 16.08% | 28.76% | 29.79% | 31.26% |
| Cost of Revenue | 26.09% | 32.46% | 28.53% | 32.26% | 60.51% |
| Gross Profit | 17.24% | 11.95% | 28.81% | 29.27% | 23.50% |
| SG&A Expenses | 3.12% | 22.19% | 17.73% | 18.54% | 25.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.51% | 29.83% | 73.46% | 30.34% | 58.89% |
| Operating Income | 38.64% | -4.34% | -54.47% | 28.72% | -15.58% |
| Income Before Tax | 41.49% | 19.95% | -50.80% | 37.07% | -10.01% |
| Income Tax Expenses | -48.94% | 20.24% | 3.14% | 62.16% | 396.91% |
| Earnings from Continuing Operations | 85.95% | 19.84% | -66.21% | 30.01% | -45.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.95% | 19.84% | -66.21% | 30.01% | -45.15% |
| EBIT | 38.64% | -4.34% | -54.47% | 28.72% | -15.58% |
| EBITDA | 33.19% | -4.16% | -48.25% | 25.10% | -13.71% |
| EPS Basic | 89.94% | 26.15% | -64.31% | 36.79% | -44.07% |
| Normalized Basic EPS | 44.53% | 6.24% | -48.05% | 44.22% | -8.22% |
| EPS Diluted | 89.84% | 25.40% | -64.29% | 39.58% | -43.41% |
| Normalized Diluted EPS | 43.04% | 5.41% | -48.07% | 45.68% | -5.77% |
| Average Basic Shares Outstanding | -2.10% | -5.00% | -5.29% | -4.96% | -1.95% |
| Average Diluted Shares Outstanding | -1.08% | -4.25% | -5.27% | -5.92% | -4.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |